Ismael Shapiro posted an update in the group Health 5 years, 10 months ago
A New Drug, Developed At John Hopkins, Could Be The First To Slow The Progression Of Parkinson’s Disease. The Drug, NLY01, Similar To A Group Of Drugs Used In Managing Type 2 Diabetes, Was Found To Be Effective In Stopping The Disease Progression In Mice. Hoping For The Best In Human Trials!
Phase 2 Parkinson's Trial of NLY01 in Protecting Neurons Fully EnrolledNeuraly announced 255 early-stage patients were testing NLY01 and its ability to slow or stop motor progression; results due by mid-2023.